# A Study to Evaluate the Acceptability and Preference for Contraceptive Options as Proxy for HIV Prevention Methods

> **NCT02404038** · NA · UNKNOWN · sponsor: **Desmond Tutu HIV Centre** · enrollment: 131 (actual)

## Conditions studied

- HIV

## Interventions

- **DRUG:** Nur-Isterate
- **DEVICE:** Nuvaring
- **DRUG:** Triphasil

## Key facts

- **NCT ID:** NCT02404038
- **Lead sponsor:** Desmond Tutu HIV Centre
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-07
- **Primary completion:** 2017-07-14
- **Final completion:** 2020-02-28
- **Target enrollment:** 131 (ACTUAL)
- **Last updated:** 2019-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02404038

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02404038, "A Study to Evaluate the Acceptability and Preference for Contraceptive Options as Proxy for HIV Prevention Methods". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT02404038. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*